Legend Biotech Corporation
LEGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$158,133 | -$520,118 | -$445,724 | -$407,196 |
| Dep. & Amort. | $23,359 | $20,451 | $18,392 | $13,917 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $68,941 | $47,680 | $34,338 | $20,158 |
| Change in WC | $20,036 | -$71,344 | $181,029 | $161,834 |
| Other Non-Cash | -$98,236 | $130,055 | $10,684 | $12,822 |
| Operating Cash Flow | -$144,033 | -$393,276 | -$201,281 | -$198,465 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14,105 | -$20,084 | -$20,927 | -$42,197 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$2,712,249 | -$4,863,149 | -$654,971 | -$377,956 |
| Inv. Sales/Matur. | $1,930,151 | $5,076,534 | $614,859 | $230,081 |
| Other Inv. Act. | -$54,341 | -$100,515 | -$16,053 | -$4,911 |
| Investing Cash Flow | -$850,544 | $92,786 | -$77,092 | -$194,983 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4,018 | -$3,755 | -$2,596 | -$1,419 |
| Stock Issued | $0 | $583,688 | $377,643 | $623,440 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,716 | $211,557 | $2,929 | $4,642 |
| Financing Cash Flow | $5,698 | $791,490 | $377,976 | $626,663 |
| Forex Effect | -$2,085 | $682 | -$2,510 | $34 |
| Net Chg. in Cash | -$990,964 | $491,682 | $97,093 | $233,249 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,277,713 | $786,031 | $688,938 | $455,689 |
| End Cash | $286,749 | $1,277,713 | $786,031 | $688,938 |
| Free Cash Flow | -$158,138 | -$415,998 | -$223,556 | -$243,869 |